These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9233575)

  • 1. The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines.
    Spets H; Jernberg-Wiklund H; Sambade C; Söderberg O; Nilsson K
    Br J Haematol; 1997 Jul; 98(1):126-33. PubMed ID: 9233575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
    Jernberg H; Pettersson M; Kishimoto T; Nilsson K
    Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
    Cheung WC; Van Ness B
    Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M; De Vos J; Mechti N; Klein B
    Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
    Levy Y; Labaume S; Colombel M; Brouet JC
    Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival.
    Spets H; Strömberg T; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
    Eur J Haematol; 2002 Aug; 69(2):76-89. PubMed ID: 12366710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses.
    Hsu JH; Shi Y; Hu L; Fisher M; Franke TF; Lichtenstein A
    Oncogene; 2002 Feb; 21(9):1391-400. PubMed ID: 11857082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
    Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M
    Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokineticin-1/endocrine gland-derived vascular endothelial growth factor is a survival factor for human multiple myeloma cells.
    Li QF; Zhu HY; Yang YF; Liu J; Xiao FJ; Zhang QW; Wu CT; Wang H; Wang LS
    Leuk Lymphoma; 2010 Oct; 51(10):1902-12. PubMed ID: 20795791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
    Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
    J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?
    Kovacs E
    Leuk Res; 2010 Jul; 34(7):912-6. PubMed ID: 19762082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
    Bataille R; Klein B
    Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.
    Jourdan M; Tarte K; Legouffe E; Brochier J; Rossi JF; Klein B
    Eur Cytokine Netw; 1999 Mar; 10(1):65-70. PubMed ID: 10210775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
    Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro growth pattern of myeloma cells in liquid suspension or semi-solid culture containing interleukin-6.
    Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Okada T; Okada H; Imura H
    Int J Hematol; 1991 Feb; 54(1):41-7. PubMed ID: 1954351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth mechanism of human myeloma cells by interleukin-6.
    Kawano MM; Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X
    Int J Hematol; 2002 Aug; 76 Suppl 1():329-33. PubMed ID: 12430875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin 6 in the growth of myeloma-derived cell lines.
    Barut BA; Zon LI; Cochran MK; Paul SR; Chauhan D; Mohrbacher A; Fingeroth J; Anderson KC
    Leuk Res; 1992 Oct; 16(10):951-9. PubMed ID: 1405708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.